Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Identification of TAP2 as a novel immune target in human cancers: insights from integrated bioinformatics and experimental approaches

Fig. 3

Prognosis implication of TAP2 in human cancers. A Based on univariate Cox regression and Kaplan–Meier model, TAP2 expression was associated with overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), and progression-free interval (PFI). Red indicates that PDIA3 is a risk factor affecting the prognosis of cancer patients, while blue indicates a protective factor. Only results with P < 0.05 are shown. B Forest maps showing the prognostic effect of TAP2 in pan-cancer were prepared using univariate Cox regression method. Red indicates TAP2 is a statistically significant risk factor for prognosis, and blue indicates TAP2 is a protective factor. C–F Kaplan–Meier overall survival curves of TAP2 in BLCA (C), OV (D), LGG (E) and ACC (F)

Back to article page